Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Jackson

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 17, 2020
Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based MethodsNatalia Kunst, Edward C F Wilson, David Glynn, et al.
The Lancet. Infectious Diseases|May 13, 2021
Applying prospective genomic surveillance to support investigation of hospital-onset COVID-19William L Hamilton, Tom Fieldman, Aminu Jahun, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Uncovering the Signatures of Cellular Senescence in the Human Dorsolateral Prefrontal CortexNicholas Sloan, Jason Mares, Aidan Daly, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2006
Synthesis and evaluation of (2-phenethyl-2H-1,2,3-triazol-4-yl)(phenyl)methanones as Kv1.5 channel blockers for the treatment of atrial fibrillationBenjamin E Blass, Keith Coburn, Wenlin Lee, et al.
Elife|August 24, 2021
Superspreaders drive the largest outbreaks of hospital onset COVID-19 infectionsChristopher Jr Illingworth, William L Hamilton, Ben Warne, et al.
Circulation|October 15, 2003
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part IIMorteza Naghavi, Peter Libby, Erling Falk, et al.
Circulation|October 8, 2003
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part IMorteza Naghavi, Peter Libby, Erling Falk, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 17, 2020
Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based MethodsNatalia Kunst, Edward C F Wilson, David Glynn, et al.
The Lancet. Infectious Diseases|May 13, 2021
Applying prospective genomic surveillance to support investigation of hospital-onset COVID-19William L Hamilton, Tom Fieldman, Aminu Jahun, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Uncovering the Signatures of Cellular Senescence in the Human Dorsolateral Prefrontal CortexNicholas Sloan, Jason Mares, Aidan Daly, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2006
Synthesis and evaluation of (2-phenethyl-2H-1,2,3-triazol-4-yl)(phenyl)methanones as Kv1.5 channel blockers for the treatment of atrial fibrillationBenjamin E Blass, Keith Coburn, Wenlin Lee, et al.
Elife|August 24, 2021
Superspreaders drive the largest outbreaks of hospital onset COVID-19 infectionsChristopher Jr Illingworth, William L Hamilton, Ben Warne, et al.
Circulation|October 15, 2003
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part IIMorteza Naghavi, Peter Libby, Erling Falk, et al.
Circulation|October 8, 2003
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part IMorteza Naghavi, Peter Libby, Erling Falk, et al.
Pageof 7